Stem Cell Research (Sep 2024)

Generation of hiPSC lines from four glutaric aciduria type I (GA1) patients carrying pathogenic biallelic variants in GCDH

  • Imke M.E. Schuurmans,
  • Clara D.M. van Karnebeek,
  • Anita D.M. Hoogendoorn,
  • Antonia Ribes,
  • Nael Nadif Kasri,
  • Alejandro Garanto

Journal volume & issue
Vol. 79
p. 103481

Abstract

Read online

GCDH encodes for the enzyme catalyzing the sixth step of the lysine degradation pathway. Autosomal recessive variants in GCDH are associated with glutaric aciduria type I (GA1), of which a wide genotypic spectrum of pathogenic variants have been described. In this study, hiPSC lines derived from four GA1 patients with different genotypes were generated and fully characterized. Two patients carry compound heterozygous variants in GCDH, while the other two patients carry a variant in homozygosis. These hiPSC lines can significantly contribute to better understand the molecular mechanism underlying GA1 and provide excellent models for the development of new therapeutic strategies.